Pharma Business
- All
- News
- Videos
-
Nifty Falls Below 25,000, Sensex Slips Under 82,000 In Early Trade
Indian stock markets came under pressure on Friday as selling by Foreign Portfolio Investors (FPIs) weighed on investor sentiment.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
Sensex Opens Lower But Holds Above 74,000-Mark Day After Rally
The Indian benchmark indices opened marginally low on Friday amid weak global cues, as selling was seen in the IT, PSU Bank and pharma sectors in the early trade.
-
Indian Share Market Rings Into New Year With Flat Trajectory
The domestic benchmark indices opened flat on Wednesday as selling was seen in auto, PSU bank, financial service, pharma and metal sectors on Nifty.
-
Tax Benefits, Intellectual Property Rights On Pharma Industry's Budget Wishlist
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
Blockchain Tech Helping Singapore Pharma Firm Prevent Administration of Expired COVID-19 Vaccines
Singapore’s Zuellig Pharma is using a new “eZTracker” app to filter out improperly stored or expired vaccines from being distributed for administration. The vaccine management system is based on SAP blockchain that enables end-to-end tracking and reporting of multiple business processes and objects.
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
PSU Banks Drag Markets; Sensex Slumps 430 Points To Close At 33,317 Level, Nifty Settles Below 10,250
The top drags in the Sensex pack were Sun Pharma, State Bank of India, ICICI Bank, Mahindra & Mahindra and Maruti Suzuki.
-
Trading Calls: Buy Ashok Leyland, Aurobindo Pharma, Says Expert
Shares in the other Asian markets traded with a cautious mood as investors braced for an event-packed week headlined by US inflation data and the first House testimony by the new head of the Federal Reserve.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates
Total revenue from operations fell 16 per cent to 66.53 billion rupees.
-
Nifty Falls Below 25,000, Sensex Slips Under 82,000 In Early Trade
Indian stock markets came under pressure on Friday as selling by Foreign Portfolio Investors (FPIs) weighed on investor sentiment.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
Sensex Opens Lower But Holds Above 74,000-Mark Day After Rally
The Indian benchmark indices opened marginally low on Friday amid weak global cues, as selling was seen in the IT, PSU Bank and pharma sectors in the early trade.
-
Indian Share Market Rings Into New Year With Flat Trajectory
The domestic benchmark indices opened flat on Wednesday as selling was seen in auto, PSU bank, financial service, pharma and metal sectors on Nifty.
-
Tax Benefits, Intellectual Property Rights On Pharma Industry's Budget Wishlist
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
Blockchain Tech Helping Singapore Pharma Firm Prevent Administration of Expired COVID-19 Vaccines
Singapore’s Zuellig Pharma is using a new “eZTracker” app to filter out improperly stored or expired vaccines from being distributed for administration. The vaccine management system is based on SAP blockchain that enables end-to-end tracking and reporting of multiple business processes and objects.
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
PSU Banks Drag Markets; Sensex Slumps 430 Points To Close At 33,317 Level, Nifty Settles Below 10,250
The top drags in the Sensex pack were Sun Pharma, State Bank of India, ICICI Bank, Mahindra & Mahindra and Maruti Suzuki.
-
Trading Calls: Buy Ashok Leyland, Aurobindo Pharma, Says Expert
Shares in the other Asian markets traded with a cautious mood as investors braced for an event-packed week headlined by US inflation data and the first House testimony by the new head of the Federal Reserve.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates
Total revenue from operations fell 16 per cent to 66.53 billion rupees.
